Resumo

ORTIGOSA BARRIOLA, Almudena; SESMERO RAMOS, Carolina; VELAYOS GONZALEZ, Mª Pilar  e  PORTOLES PEREZ, José. Nursing action related to patients on peritoneal dialysis and treatment with Cinacalcet. Rev Soc Esp Enferm Nefrol [online]. 2007, vol.10, n.3, pp.13-17. ISSN 1139-1375.

Secondary hyperparathyroidism in TCRI is a frequent complication and is associated to a high morbidity index in patients on dialysis programmes. Once it has been established, attempts should be made to slow down its development, maintaining adequate bone mineralization and protecting from vascular calcification. This last effect increases the cardiovascular risk, and the risk of amputations and even death. For this reason, there are diet recommendations and several pharmacological treatments. In 2004, Cinacalcet (Mimpara^®) appeared, which belongs to the group of calcimimetics, and was approved in Spain in 2005. In order to determine its effectiveness, five patients on peritoneal dialysis and with hyperparathyroidism were monitored, who had not responded to conservative treatment and commenced treatment with Mimpara^® in order to determine its effectiveness. A protocol has been designed for nursing attention that lets all the activities be monitored. The analytical results improved notably in all cases. The symptoms referred by patients prior to treatment disappeared after commencing treatment and no adverse side effects were noted. It is important to note that this is a short-term study with a small sample, and therefore it would be interesting to continue working on it. Close control by nursing staff favours adherence to the treatment and the diet, which reflects satisfaction in the patients in question.

Palavras-chave : Secondary hyperparathyroidism; Cinacalcet; Renal osteodystrophy; Hypocalcaemia; Diet recommendations.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )